Researchers administered a short survey to 455 cancer patients receiving radiation therapy across the country.
The survey asks if, over the last two weeks, the patient has experienced:
- Little interest or pleasure in activities
- Feeling down, depressed or hopeless
Patient answers are scored on a scale from zero to three, where zero indicates not at all, one indicates several days, two indicates more than half of the days and three indicates nearly every day. A composite score of three or more on the questions indicates risk for major depression.
Sixteen percent of patients researchers screened tested positive for depression risk. When physicians interviewed this group with the standard Structured Clinical Interview for DSM IV Disorders and compared the results to the two-question survey, the shorter survey was 83 percent accurate in indicating major depression risk, according to a news release.
More Articles on Key Specialties:
Advocate Condell to Spend $10M on Cancer Updates
Women’s Health Access Debated as Anthem BCBS Drops 10 Hospitals
New York Genome Center Opens Doors
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
